
Gilead counters AbbVie with exclusive hepatitis C drug deal of its own
CVS Health announced Monday that it plans to make Gilead Sciences' hepatitis C drugs the exclusive option for most of its consumers starting Wednesday. The announcement comes two weeks after...






